In this @-year , randomized , double-blind , placebo-controlled study , @ adult patients on a regimen of pioglitazone ( with or without metformin ) were randomly assigned to receive additional treatment with albiglutide -LSB- @ mg subcutaneous ( s.c. ) once weekly , n = @ -RSB- or matching placebo ( n = @ ) .